Search Results - "SENECAL, Delphine"

Classical Hodgkin’s lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant by Van Den Neste, Eric, Casasnovas, Olivier, André, Marc, Touati, Mohamed, Senecal, Delphine, Edeline, Véronique, Stamatoullas, Aspasia, Fornecker, Luc, Deau, Bénédicte, Gastinne, Thomas, Reman, Oumédaly, Gaillard, Isabelle, Borel, Cécile, Brice, Pauline, Fermé, Christophe

“…The Hodgkin's Lymphoma Committee of the Lymphoma Study Association (LYSA) gathered in 2012 to prepare guidelines on the management of transplant-eligible…”
Get full text

High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B‐cell lymphoma in first relapse: results of the R‐NIMP GOELAMS study by Gyan, Emmanuel, Damotte, Diane, Courby, Stéphane, Sénécal, Delphine, Quittet, Philippe, Schmidt‐Tanguy, Aline, Banos, Anne, Gouill, Steven, Lamy, Thierry, Fontan, Jean, Maisonneuve, Hervé, Alexis, Magda, Dreyfus, Francois, Tournilhac, Olivier, Laribi, Kamel, Solal‐Céligny, Philippe, Arakelyan, Nina, Cartron, Guillaume, Gressin, Remy

“…Summary The optimal management of relapsed diffuse large B‐cell lymphoma (DLBCL) is not standardized. The Groupe Ouest Est des Leucémies et aAutres Maladies du…”
Get full text

CCL5-enhanced human immature dendritic cell migration through the basement membrane in vitro depends on matrix metalloproteinase-9 by Chabot, Valérie, Reverdiau, Pascale, Iochmann, Sophie, Rico, Angélique, Sénécal, Delphine, Goupille, Caroline, Sizaret, Pierre‐Yves, Sensebé, Luc

“…The proinflammatory chemokine CC chemokine ligand 5 (CCL5) is a potent chemoattractant of immature dendritic cells (iDCs). It remains to be elucidated whether…”
Get full text

Reduced Versus Full Doses of Irradiation After 3 Cycles of Combined Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in Early Stage Hodgkin Lymphomas: Results of a Randomized Trial by ARAKELYAN, Nina, JAIS, Jean-Philippe, DELWAIL, Vincent, BRIERE, Josette, MOLES-MOREAU, Marie-Pierre, SENECAL, Delphine, BERTHOU, Christian, DESABLENS, Bernard, COLONNA, Pierre, ANDRIEU, Jean-Marie

“…The combination of 3 cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) and a tailored, extended irradiation schedule has been used to treat…”
Get full text

Fatal algaemia in patient with chronic lymphocytic leukemia by Lanotte, Philippe, Baty, Gaelle, Senecal, Delphine, Dartigeas, Caroline, Bailly, Eric, Duong, Thanh Hai, Chandenier, Jacques, Goudeau, Alain

Get full text

Hodgkin's disease variant of Richter's syndrome. Two cases and literature review by Dujardin, Fanny, Lefrancq, Thierry, Bléchet, Claire, Boni-Boka, Michel, Sénecal, Delphine, Desmoulins, Isabelle, Guyétant, Serge

“…We report the clinical and immunohistological features of two cases of chronic lymphocytic leukaemia (CLL) with Hodgkin's transformation. These cases occurred…”
Get more information

The need for a better definition of therapeutic indications of carboxypeptidase in delayed elimination of methotrexate by Blasco, Hélène, Silly, Stéphanie, Tournamille, Jean-François, Gyan, Emmanuel, Sénécal, Delphine, André, Virginie, Colombat, Philippe, Le Guellec, Chantal

“…High dose methotrexate (HD-MTX) may cause nonhaematological and haematological toxicities. MTX overexposure may be subsequent to administration errors or to…”
Get more information

Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study by Dartigeas, Caroline, Quinquenel, Anne, Ysebaert, Loïc, Dilhuydy, Marie-Sarah, Anglaret, Bruno, Slama, Borhane, Le Du, Katell, Tardy, Stéphanie, Tchernonog, Emmanuelle, Orfeuvre, Hubert, Voillat, Laurent, Guidez, Stéphanie, Malfuson, Jean-Valère, Dupuis, Sandrine, Deslandes, Marine, Feugier, Pierre, Leblond, Véronique

“…We conducted an observational study (FIRE) to understand the effectiveness and safety outcomes of ibrutinib in patients with chronic lymphocytic leukemia (CLL)…”
Get full text

PET Adapted Salvage Therapy for Advanced Hodgkin Lymphomas: Towards the Suppression of Positive Interim PET Unfavorable Prognosis? a Report of the Goelams Multicentric Phase 2 Trial LH2007 by Carras, Sylvain, Dubois, Benjamin, Senecal, Delphine, Quittet, Philippe, Vuillez, jean-Philippe, peoc'H, Michel, Jais, jean-Philippe, Lamy, Thierry, Molina, Lysiane

“…Introduction: Continuous improvement in the management of Hodgkin Lymphoma (HL) has brought to favorable outcome for the majority of patients. However,…”
Get full text

Interim PET Response-adapted Strategy in Untreated Advanced Stage Hodgkin Lymphoma: Results of GOELAMS LH 2007 Phase 2 Multicentric Trial by Carras, Sylvain, Dubois, Benjamin, Senecal, Delphine, Jais, Jean-Philippe, Peoc'h, Michel, Quittet, Philippe, Foussard, Charles, Bouabdallah, Krimo, Gastinne, Thomas, Jourdan, Eric, Sanhes, Laurence, Ertault, Marjan, Lamy, Thierry, Molina, Lysiane

“…Hodgkin lymphoma is a curable disease with outcomes depending on initial prognostic factors and interim treatment response. Here, we conducted a phase II trial…”
Get full text

Twenty‐year disease and treatment‐associated mortality rates of patients with Hodgkin lymphoma of clinical stages IIIB and IV prospectively treated with 3‐month anthracycline‐based chemotherapy followed by extended high‐dose radiation by Sénécal, Delphine, Jais, Jean‐Philippe, Desablens, Bernard, Berthou, Christian, Casassus, Philippe, Moles, Marie‐Pierre, Delwail, Vincent, Gastinne, Thomas, Colonna, Pierre, Andrieu, Jean‐Marie

“…BACKGROUND. In 1981, the authors developed an original strategy combining 3 cycles of doxorubicin (adriamycin), bleomycin, vinblastine, and dacarbazine (ABVD)…”
Get full text

Final results of a randomized phase II GELA/LYSA study of rituximab plus ACVBP or CHOP, using a PET-driven consolidation strategy, in patients with high-risk diffuse large B-cell lymphoma (DLBCL) by Casasnovas, Rene-Olivier, Ysebaert, Loic, Thieblemont, Catherine, Coiffier, Bertrand, Bologna, Serge, Lepeu, Gerard, Delmer, Alain, Plantier, Isabelle, Gabarre, Jean, Andre, Marc, Senecal, Delphine, Fruchart, Christophe, Meignan, Michel, Berriolo-Riedinger, Alina, Bardet, Stephane, Molina, Thierry Jo, Jais, Jean-Philippe, Haioun, Corinne, Tilly, Herve, Morschhauser, Franck

“…Abstract only…”
Get full text

Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment by Monjanel, Hélène, Hourioux, Christophe, Arbion, Flavie, Colombat, Philippe, Lissandre, Séverine, Regner, Marie Paule, Senecal, Delphine

Get full text

The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study by Sensebé, Luc, Giraudeau, Bruno, Bardiaux, Laurent, Deconinck, Eric, Schmidt, Aline, Bidet, Marie-Laure, LeNiger, Catherine, Hardy, Elisabeth, Babault, Catherine, Senecal, Delphine

“…We performed a prospective, randomized, open, blinded end point (PROBE) study to assess the efficiency of transfusing high doses of platelets in patients with…”
Get full text

Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma by Blasco, Hélène, Senecal, Delphine, Le Gouge, Amélie, Pinard, Emmanuelle, Benz‐de Bretagne, Isabelle, Colombat, Philippe, Hulot, Jean‐Sébastien, Chatelut, Etienne, Le Guellec, Chantal

“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT Although treated using the same high‐dose methotrexate (HD‐MTX)‐based multiagent chemotherapy, patients with primary…”
Get full text

Long Term Molecular Remissions after Autologous Haematopoietic Stem Cell Transplant in Follicular Lymphoma by Lissandre, Séverine, Vourch, Patrick, Desbois, Isabelle, Benboubker, Lotfi, Dartigeas, Caroline, Delain, Martine, Senecal, Delphine, Colombat, Philippe, Gyan, Emmanuel

“…Background and aim of the study: Autologous stem cell transplant (ASCT) has been shown to be an effective treatment for first-line and relapsed follicular…”
Get full text

High Response Rate and Low Toxicity of Rituximab, Vinorelbine, Ifosfamide, Mitoxantrone and Prednisone Combination for the Treatment of Diffuse Large B Cell Lymphoma In First Relapse: Early Results of the R-NIMP GOELAMS Study by Gyan, Emmanuel, Senecal, Delphine, Quittet, Philippe, Foussard, Charles, Banos, Anne, Le Gouill, Steven, Dauriac, Charles, Léger, Julie, Fontan, Jean, Damotte, Diane, Maisonneuve, Hervé, Alexis, Magda, Dreyfus, Francois, Courby, Stéphane, Dutel, Jean-Louis, Tournilhac, Olivier, Laribi, Kamel, Solal-Céligny, Philippe, Mevel, Annick Le Pourhiet-Le, Arakelyan, Nina, Jardel, Henry, Gressin, Remy

“…Abstract 2796 Diffuse large B-cell lymphoma (DLBCL) relapse prognosis is poor, and the optimal salvage treatment is not known. In a previous pilot study,…”
Get full text

Final Results of the RiPAD+C Regimen Including Velcade In Front Line Therapy for Elderly Patients with Mantle Cell Lymphoma. A Phase II Prospective Study of the GOELAMS Group by Gressin, Remy, Houot, Roch, Uribe, Mario Ojeda, Mounier, Christiane, Bouabdallah, Krimo, Alexis, Magda, Senecal, Delphine, Molles, Marie Pierre, Tournilhac, Olivier, Park, Sophie, Rodon, Philippe, Yamani, Abderrazak El, Sutton, Laurent, Lioure, Bruno, Assouline, David, Harousseau, Jean-Luc, Maisonneuve, Hervé, Maugendre, Sylvie Caulet, Le Gouill, Steven

“…Abstract 2791 Elderly mantle cell lymphoma (MCL) patients (pts) do not benefit from dose-intensive chemotherapy upfront.1 The GOELAMS group recently…”
Get full text

Successful Treatment of Primary Refractory Bulky Diffuse Large B-Cell Lymphomas with Concomitant Radio-Chemotherapy Followed by Autologous Stem Cell Transplantation : A Single Center Experience by Couturier, Marie-Anne, Champeaux-Orange, Elise, Senecal, Delphine, Lissandre, S.éverine, Benboubker, Lotfi, Barillot, Isabelle, Calais, Gilles, Colombat, Philippe, Gyan, Emmanuel

“…Diffuse large B cell lymphomas (DLBCL) with bulky presentation display a poor prognosis because of a substantial rate of primary refractory disease. Second and…”
Get full text

Stromal‐derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony‐stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells by Carion, Alexandra, Benboubker, Lotfi, Hérault, Olivier, Roingeard, Françoise, Degenne, Michel, Senecal, Delphine, Desbois, Isabelle, Colombat, Philippe, Charbord, Pierre, Binet, Christian, Domenech, Jorge

“…The roles of the chemokine stromal‐derived factor 1 (SDF‐1) and the matrix metalloproteinase 9 (MMP‐9) in haematopoietic progenitor cell (HPC) mobilization are…”
Get full text